Page 130 - 《中国药房》2021年07期

症以及有抑郁高风险的 T2DM 患者可推荐首选二甲双 Psychosom Med，2020，82（4）：350-358.
胍进行治疗；对于 T2DM 合并抑郁症的患者，二甲双胍 [12] MOULTON C D，PICKUP J C，ROKAKIS A S，et al. The
将来有望替代传统抗抑郁药物治疗；对于非T2DM的抑 prospective association between inflammation and depres-
郁症患者，二甲双胍也可能成为新的治疗选择。然而， sive symptoms in type 2 diabetes stratified by sex[J]. Dia-
我国目前尚未开展相关的大型的人群队列研究，关于二 betes Care，2019，42（10）：1865-1872.
甲双胍改善抑郁的机制及在中国人群中的效果及应用， [13] KOLB H，MARTIN S. Environmental/lifestyle factors in
the pathogenesis and prevention of type 2 diabetes[J].
仍需要进一步大规模、高质量的研究证实。
参考文献 BMC Med，2017，15（1）：131.
[14] LOTFALIANY M，HOARE E，JACKA F N，et al. Varia-
[ 1 ] 中华医学会精神医学分会抑郁障碍研究协作组.抑郁症
tion in the prevalence of depression and patterns of asso-
认知症状评估与干预专家共识[J].中华精神科杂志， ciation，sociodemographic and lifestyle factors in commu-
2020，53（5）：369-376.
nity-dwelling older adults in six low- and middle-income
[ 2 ] NEMEROFF C B. Prevalence and management of treat-
countries[J]. J Affect Disord，2019，251：218-226.
ment resistant depression[J]. J Clin Psyc，2007，68（8）： [15] HOUSHMAND F，BARATI M，GOLAB F，et al. Metfor-
17-25.
min-induced AMPK activation stimulates remyelination
[ 3 ] SHARMA A N，LIGADE S S，SHARMA J N，et al. GLP-
through induction of neurotrophic factors，downregulation
1 receptor agonist liraglutide reverses long-term atypical +
antipsychotic treatment associated behavioral depression of NogoA and recruitment of Olig2 precursor cells in the
cuprizone murine model of multiple sclerosis[J]. Daru，
and metabolic abnormalities in rats[J]. Metab Brain Dis，
2019，27（2）：583-592.
2014，30（2）：519-527.
[ 4 ] 中华医学会，中华医学会杂志社，中华医学会全科医学 [16] LI J，DENG J，SHENG W，et al. Metformin attenuates Al-
分会，等. 2 型糖尿病基层诊疗指南：实践版：2019[J].中 zheimer’s disease-like neuropathology in obese，leptin-re-
sistant mice[J]. Pharmacol Biochem Behav，2012，101
华全科医师杂志，2019，18（9）：810-818.
（4）：564-574.
[ 5 ] KESSING L V，RYTGAARD H C，EKSTRM C T，et al.
Antidiabetes agents and incident depression：a nationwide [17] PATRONE C，ERIKSSON O，LINDHOLM D. Diabetes
drugs and neurological disorders：new views and therapeu-
population-based study[J]. Diabetes Care，2020，43（12）：
tic possibilities[J]. Lancet Diabetes Endocrinol，2014，2
3050-3060.
[ 6 ] KHALEDI M，HAGHIGHATDOOST F，FEIZI A，et al. （3）：256-262.
[18] ASADBEGI M，YAGHMAEI P，SALEHI I，et al. Neuro-
The prevalence of comorbid depression in patients with
protective effects of metformin against Abeta-mediated in-
type 2 diabetes：an updated systematic review and me-
ta-analysis on huge number of observational studies[J]. hibition of long-term potentiation in rats fed a high-fat
Acta Diabetologica，2019，56（6）：631-650. diet[J]. Brain Res Bull，2016，121：178-185.
[ 7 ] GRAHAM EVA A，DESCHÊNES SONYA S，KHALIL [19] MILLER A H，RAISON C L. The role of inflammation in
MARINA N，et al. Measures of depression and risk of depression：from evolutionary imperative to modern treat-
type 2 diabetes：a systematic review and meta-analysis[J]. ment target[J]. Nat Rev Immunol，2016，16（1）：22-34.
J Affect Disord，2020，265：224-232. [20] DE LA ROCA-CHIAPAS J M，HERNANDEZ-GONZA-
[ 8 ] POUWER F，SCHRAM M T，IVERSEN M M，et al. How LEZ M，CANDELARIO M，et al. Association between de-
25 years of psychosocial research has contributed to a bet- pression and higher glucose levels in middle-aged Mexi-
ter understanding of the links between depression and dia- can patients with diabetes[J]. Rev Invest Clin，2013，65
betes[J]. Diabet Med，2020，37（3）：383-392. （3）：209-213.
[ 9 ] FAROOQI A，KHUNTI K，ABNER S，et al. Comorbid de- [21] GUO M，MI J，JIANG Q M，et al. Metformin may pro-
pression and risk of cardiac events and cardiac mortality duce antidepressant effects through improvement of cogni-
in people with diabetes：a systematic review and me- tive function among depressed patients with diabetes mel-
ta-analysis[J]. Diabetes Res Clin Pract，2019，156：107816. litus[J]. Clin Exp Pharmacol Physiol，2014，41（9）：
[10] MOULTON C D，HOPKINS C W P，ISMAIL K，et al. Re- 650-656.
positioning of diabetes treatments for depressive symp- [22] JI L N，HAN P，WANG X Y，et al. Randomized clinical
toms：a systematic review and meta-analysis of clinical trial of the safety and efficacy of sitagliptin and metformin
trials[J]. Psychoneuroendocrinology，2018，94：91-103. co-administered to Chinese patients with type 2 diabetes
[11] ZHENG T，GE B，QIN L，et al. Association of plasma mellitus[J]. J Diabetes Investig，2016，7（5）：727-736.
DPP4 activity and brain-derived neurotrophic factor with [23] ZOU X H，SUN L H，YANG W，et al. Potential role of in-
moderate to severe depressive symptoms in patients with sulin on the pathogenesis of depression[J]. Cell Prolifera-
type 2 diabetes：results from a cross-sectional study[J]. tion，2020，53（5）：e12806.

·888 · China Pharmacy 2021 Vol. 32 No. 7 中国药房 2021年第32卷第7期